Valo Therapeutics
Developer of novel cancer immunotherapy designed to treat cancer patients. The company's immunotherapy adsorbs tumour-specific peptides to the surface of an oncolytic virus, eliciting an enhanced adap...
Valuation
$0
Share Price
N/A
Total Raised
$44.7M
Last Round
N/A